Activities / achievements:- Responsible for routine QA/GMP tasks (deviations, CAPAs, supplier approval, etc).- Responsible for QA documentation (PQRs, stability studies, change control, etc).- BPR product registrations for biocides in PT2,3,4,5 in the EU.- Registration of vet. medicinal products in the EU by MRP (new API, non-generic).- Study coordinator of (eco)toxicity- and efficacy testing for registration dossiers (in vitro, in vivo).

Activities / achievements:- Setting up a complete GMP quality system to obtain a production license for vet. medicinal products. So designing and writing all related SOPs, procedures, records, validations, risk assessments, … , and conducting related training of personnel.- Handling for QA/GMP tasks (PQRs, Stability studies, validations, etc).- Processing routine OOS, deviations, CAPAs, etc.- Responsible for Pharmacovigilance (Notifications, PSURs, DDPS, etc)- Registration of biocidal products in PT2,3,4,5 in the EU (incl BPR).- Registration of vet. medicinal products in the EU by MRP (new API, non-generic).- Renewal to registered veterinary medicinal products.

Activities / achievements:- Development of new cleaning/disinfection products and vet. medicinal products.- Developing, validating and implementing new analytical methods for the QC lab.- Developing, validating and implementing new product manufacturing processes.- Registration of biocidal products for use in PT2,3,4 in the EU (not BPR).- Registration of vet. medicinal products in the EU (new API, non-generic).- Variations to registered veterinary medicinal products.- Management of labels, SPCs, MSDSs and other product literature.

Activities / achievements:- development of different types of bone graft substitutes derived from processed donor bone (demineralised bone, cortical bone, trabecular bone, possibly supplemented with antibiotics, growth factors, etc) - development of the preparation of collagen fleeces by processing porcine pericardia

Development of radiopaque polymeric microspheres, supplemented with doxorubicin, for the treatment of hepatocellular carcinoma.

Development of thermo-induced water-based hydrogels as invertebral disc replacement.